Fed Pullback Pledge...
Health Care: Drugs
Cornerstone Therapeutics Inc. (CRTX: NASDAQ)
$8.35 -0.10 | -1.18%
06/19/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 8.45 |
| 52 Week High | 10.37 |
| 52 Week Low | 3.10 |
| Avg. Daily Vol. (Mil) | 0.09 |
| Beta (3 year) | 0.16 |
| Share Related Items | |
| Mkt Cap (Mil) | 226.48 |
| Shares Out (Mil) | 26.80 |
| Float (Mil) | 8.92 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.70 |
| LT Debt/ Equity | 0.53 |
| Total Debt / Equity | 0.53 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.72 |
| Price/Book | 1.34 |
| Price/Cash Flow | 22.70 |
| Per Share Data | |
| Earnings | -0.30 |
| Sales | 4.92 |
| Book Value | 6.33 |
| Cash Flow | 0.37 |
| Business Summary | |
|---|---|
| Cornerstone Therapeutics, Inc., is a specialty pharmaceutical company which commercializes products for the hospital and adjacent specialty markets. | |
| General Information | |
| 1255 Crescent Green Drive
Suite 250 Cary, NC 27518 |
|
| www.crtx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 105 | |
| CEO: Mr. Craig A. Collard | |
| Short Interest | |
| Current Month (Mil) | 0.28 |
| Previous Month (Mil) | 0.28 |
| Short Interest Ratio (Days) | 3.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -2.10 |
| Return on Investments | -3.00 |
| Profitability | |
| Gross Margin | 65.70 |
| EBIT Margin | -14.70 |
| Profit Margin | -5.80 |
Portfolios with CRTX
- Portfolio NameUser Type
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- User0730
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Health-Care Stocks Outpe...
- Userrussbow98 Portfolio 1
- UserSUPRATRADE-2609091346
- UserShooting Stocks
- UserCREW
Latest CRTX Headlines from TheStreet
- Cornerstone Therapeutics Inc. Stock Upgraded (CRTX) 03.04.13 | 04:03 am
- 31 Drugs Facing FDA Approval in 2012-2013 08.20.12 | 08:08 am
- 5 Stocks Under $10 Set to Soar 07.26.12 | 12:07 pm
- 4 Biotech Stocks Under $10 With Relative Strength 07.24.12 | 02:07 pm
- Cornerstone Therapeutics Inc. Stock Downgraded (CRTX) 07.10.12 | 05:07 am
- Cornerstone Therapeutics Inc. Stock Downgraded (CRTX) 11.11.11 | 05:11 am
- Cornerstone Stock Soars (CRTX) 10.04.11 | 04:10 pm
- 10 Health-Care Stocks Outperforming the Index 06.07.11 | 01:06 pm
- Cornerstone Therapeutics Inc. Stock Upgraded (CRTX) 03.31.11 | 06:03 pm
- Momentum BioPharmaceutical Play: Stocks Under $10
03.31.11 | 06:03 am
Press Releases for CRTX
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches Investigation In Possible Breaches Of Fiduciary Duty By The Board Of Cornerstone Therapeutics, Inc. In Connection With A Going Private Proposal - Business Wire 02.25.13 | 06:02 pm
- Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Cornerstone Therapeutics Inc. Shareholders - Business Wire 02.25.13 | 03:02 pm
- Cornerstone Therapeutics Shareholder Alert: Briscoe Law Firm And Powers Taylor, LLP Investigate Going Private Proposal - Business Wire 02.22.13 | 04:02 pm
- Cornerstone Therapeutics Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Chiesi Farmaceutici SpA's Going Private Offer - PR Newswire 02.21.13 | 09:02 am
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches Investigation In Possible Breaches Of Fiduciary Duty By The Board Of Cornerstone Therapeutics, Inc. In Connection With A Going Private Proposal - PR Newswire 02.20.13 | 10:02 am
- New Research Indicates Treating Neonatal Respiratory Distress Syndrome With CUROSURF® Results In Lower Rate Of Mortality Compared To Competitive Surfactants - Business Wire 09.12.11 | 08:09 am
- Cornerstone Therapeutics To Present At Rodman & Renshaw 12th Annual Healthcare Conference - PR Newswire 09.08.10 | 08:09 am
- Cornerstone Therapeutics Announces Development Of Generic For Tussionex® - PR Newswire 08.05.10 | 09:08 am
- Cornerstone Therapeutics Licenses Alpha-7 Technology To Targacept - PR Newswire 08.03.10 | 08:08 am
- Cornerstone Therapeutics Announces Collaboration With The Cough Company - PR Newswire 08.02.10 | 08:08 am
Partner Headlines for CRTX
- Bad News for Cornerstone - Analyst Blog - NASDAQ 09.20.12 | 09:09 pm
- Cornerstone Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 09.10.12 | 02:09 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - NASDAQ 08.30.12 | 12:08 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 08.30.12 | 09:08 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 03.20.12 | 09:03 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Rio Tinto Gets Approval for Chinalco Mineral Exploration in China - NASDAQ 11.25.11 | 08:11 am
- Cornerstone Therapeutics to withdraw three painkillers - Reuters 11.22.10 | 11:11 am
- Cornerstone Tops Consensus - Analyst Blog - Zacks 03.08.10 | 12:03 pm
